SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-24-007566
Filing Date
2024-11-22
Accepted
2024-11-22 09:28:01
Documents
17
Period of Report
2024-11-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K upxi_8k.htm   iXBRL 8-K 27398
2 PRESS RELEASE upxi_ex991.htm EX-99.1 6287
8 upxi_ex991img2.jpg GRAPHIC 3785
  Complete submission text file 0001477932-24-007566.txt   170802

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA upxi-20241120.xsd EX-101.SCH 5874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE upxi-20241120_lab.xml EX-101.LAB 15213
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE upxi-20241120_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE upxi-20241120_pre.xml EX-101.PRE 9640
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE upxi-20241120_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT upxi_8k_htm.xml XML 4007
Mailing Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607
Business Address 3030 ROCKY POINT DRIVE SUITE 420 TAMPA FL 33607 701-353-5425
UPEXI, INC. (Filer) CIK: 0001775194 (see all company filings)

IRS No.: 833378978 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-40535 | Film No.: 241486929
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)